Pregabalin Capsule
Product Images NDC 71205-696

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71205-696). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Pregabalin 01)

FDA Label Image

Figure 1 (Pregabalin 02)

FDA Label Image

Figure 2 (Pregabalin 03)

FDA Label Image

Figure 3 (Pregabalin 04)

FDA Label Image

Figure 4 (Pregabalin 05)

Figure 4 (Pregabalin 05)
This text provides information about the dosage of Pregabalin, a medication, for patients. The suggested dosage is 200 mg of Pregabalin to be taken three times a day. Additionally, there is a reference to a placebo as well as percentages indicating the improvement in pain experienced by patients. The exact percentages are not readable in the provided text.*
FDA Label Image

Figure 5 (Pregabalin 06)

Figure 5 (Pregabalin 06)
This text provides information on the percentage of patients who improved during a study. The study evaluated the effects of Pregabalin at two different doses (100 mg and 50 mg taken three times a day) compared to a placebo. The text also includes a graph showing the percent improvement in pain from baseline, with values ranging from 0 to 100.*
FDA Label Image

Figure 6 (Pregabalin 07)

FDA Label Image

Figure 7 (Pregabalin 08)

Figure 7 (Pregabalin 08)
Not available*
FDA Label Image

Figure 9 (Pregabalin 09)

FDA Label Image

Figure 10 (Pregabalin 10)

FDA Label Image

Figure 11 (Pregabalin 11)

Figure 11 (Pregabalin 11)
The text provides a table showing the percent of subjects improved over time. It indicates that there are 100% of subjects improved. There is also a list of numbers ranging from 210 to 290. Additionally, it mentions a comparison between "Pregabalin" and "Placebo" regarding the percent improvement from Baseline to Week 12 BOCF.*
FDA Label Image

Figure 12 (Pregabalin 12)

Figure 12 (Pregabalin 12)
The available text does not provide a useful description.*
FDA Label Image

71205-696-60 (Pregabalin 14)

71205-696-60 (Pregabalin 14)
This text appears to be a description of a medication package. The medication is called Pregabalin and it comes in 50mg capsules. The package contains 60 capsules. The lot number is 00000 and the serial number is MASTER. The medication is dispensed with a medication guide for each patient. The capsules are white with an opaque colored cap and body, with "SG" imprinted on the cap and "351" on the body. The manufacturer is ScieGen Pharmaceuticals, Inc. based in Hauppauge, NY. The medication should be stored at 25°C (77°F) and the expiration date is 00/00/00.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.